239 related articles for article (PubMed ID: 19090925)
21. Parallel screening: a novel concept in pharmacophore modeling and virtual screening.
Steindl TM; Schuster D; Laggner C; Langer T
J Chem Inf Model; 2006; 46(5):2146-57. PubMed ID: 16995745
[TBL] [Abstract][Full Text] [Related]
22. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
23. The first pharmacophore model for potent NF-kappaB inhibitors.
Tsai KC; Teng LW; Shao YM; Chen YC; Lee YC; Li M; Hsiao NW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5665-9. PubMed ID: 19726185
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model.
Kim J; Lee C; Chong Y
SAR QSAR Environ Res; 2009; 20(1-2):103-18. PubMed ID: 19343586
[TBL] [Abstract][Full Text] [Related]
25. The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds.
Tramontano E
Mini Rev Med Chem; 2008 Oct; 8(12):1298-310. PubMed ID: 18855743
[TBL] [Abstract][Full Text] [Related]
26. Imidazo[4,5-c]pyridines inhibit the in vitro replication of the classical swine fever virus and target the viral polymerase.
Vrancken R; Paeshuyse J; Haegeman A; Puerstinger G; Froeyen M; Herdewijn P; Kerkhofs P; Neyts J; Koenen F
Antiviral Res; 2008 Feb; 77(2):114-9. PubMed ID: 17997169
[TBL] [Abstract][Full Text] [Related]
27. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
Abu Hammad AM; Taha MO
J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and properties of (alpha-P-borano)-nucleoside 5'-triphosphate analogues as potential antiviral agents.
Cheek MA; Dobrikov MI; Wennefors CK; Xu Z; Hashmi SN; Shen X; Shaw BR
Nucleic Acids Symp Ser (Oxf); 2008; (52):81-2. PubMed ID: 18776263
[TBL] [Abstract][Full Text] [Related]
30. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
31. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
Yu H; Wang Z; Zhang L; Zhang J; Huang Q
Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
[TBL] [Abstract][Full Text] [Related]
32. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
[TBL] [Abstract][Full Text] [Related]
33. Discovery of potential ZAP-70 kinase inhibitors: pharmacophore design, database screening and docking studies.
Sanam R; Vadivelan S; Tajne S; Narasu L; Rambabu G; Jagarlapudi SA
Eur J Med Chem; 2009 Dec; 44(12):4793-800. PubMed ID: 19674816
[TBL] [Abstract][Full Text] [Related]
34. N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase.
Yin Z; Chen YL; Kondreddi RR; Chan WL; Wang G; Ng RH; Lim JY; Lee WY; Jeyaraj DA; Niyomrattanakit P; Wen D; Chao A; Glickman JF; Voshol H; Mueller D; Spanka C; Dressler S; Nilar S; Vasudevan SG; Shi PY; Keller TH
J Med Chem; 2009 Dec; 52(24):7934-7. PubMed ID: 20014868
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore modeling, docking, and principal component analysis based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhinovirus coat protein.
Steindl TM; Crump CE; Hayden FG; Langer T
J Med Chem; 2005 Oct; 48(20):6250-60. PubMed ID: 16190752
[TBL] [Abstract][Full Text] [Related]
36. The flavivirus polymerase as a target for drug discovery.
Malet H; Massé N; Selisko B; Romette JL; Alvarez K; Guillemot JC; Tolou H; Yap TL; Vasudevan S; Lescar J; Canard B
Antiviral Res; 2008 Oct; 80(1):23-35. PubMed ID: 18611413
[TBL] [Abstract][Full Text] [Related]
37. Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
Popovici-Muller J; Shipps GW; Rosner KE; Deng Y; Wang T; Curran PJ; Brown MA; Siddiqui MA; Cooper AB; Duca J; Cable M; Girijavallabhan V
Bioorg Med Chem Lett; 2009 Nov; 19(22):6331-6. PubMed ID: 19819138
[TBL] [Abstract][Full Text] [Related]
38. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q
Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
[TBL] [Abstract][Full Text] [Related]
39. Discovery of non-glycoside sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening.
Wu JS; Peng YH; Wu JM; Hsieh CJ; Wu SH; Coumar MS; Song JS; Lee JC; Tsai CH; Chen CT; Liu YW; Chao YS; Wu SY
J Med Chem; 2010 Dec; 53(24):8770-4. PubMed ID: 21090651
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2).
Ulmschneider S; Negri M; Voets M; Hartmann RW
Bioorg Med Chem Lett; 2006 Jan; 16(1):25-30. PubMed ID: 16246562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]